RILP and Alzheimer disease: As shown in Figures 6C,D, the effects of oral DHA upregulated the expression level of Rab7 (p < 0.01; Figures 6C,D) and RILP (p < 0.001; Figures 6C,D), compared with that of the DMSO-treated AD group.